Related Articles
Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: Comparative study of immunohistochemistry and fluorescent in situ hybridization
Potential for molecular-targeted therapy targeting human epidermal growth factor receptor-2 for invasive bladder cancer
HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer.
Cox-2 and Her2/neu co-expression in invasive bladder cancer
Amplification and clinicopathological significance of HER‑2 in Kazakh esophageal squamous cell carcinoma